Protalix Biotherapeutics Company Profile, Contacts & Intelligence
Protalix Biotherapeutics Overview
Protalix (NYSE American, TASE: PLX) is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix’s unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner. Protalix’s first product manufactured by ProCellEx, taliglucerase alfa, was approved by the FDA in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights. Protalix’s development pipeline consists of proprietary versions of recombinant therapeutic proteins that target established pharmaceutical markets, including the following product candidates: pegunigalsidase alfa, a modified stabilized version of the recombinant human α Galactosidase A protein for the treatment of Fabry disease; alidornase alfa or PRX 110, for the treatment of various human respiratory diseases or conditions; PRX 115, a plant cell-expressed recombinant PEGylated uricase for the treatment of severe gout; PRX 119, a plant cell-expressed long action DNase I for the treatment of NETs-related diseases; and others. Protalix has partnered with Chiesi Farmaceutici S.p.A., both in the United States and outside the United States, for the development and commercialization of pegunigalsidase alfa.
- Headquarters
- Il
- Website
- protalix.com
- Industry
- Biotechnology Research
- Founded
- 1994
- Stock Symbol
- AMERI
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Protalix Biotherapeutics Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Protalix Biotherapeutics People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Protalix Biotherapeutics Workforce Composition
Seniority breakdown across 28 visible profiles.
Protalix Biotherapeutics Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Protalix Biotherapeutics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Novocure | Medical Equipment Manufacturing | 1.43K | View company |
| Dexcel Pharma | Pharmaceutical Manufacturing | 520 | View company |
| Pluri | Biotechnology Research | 254 | View company |
| CytoReason | Biotechnology Research | 129 | View company |
| Evogene | Biotechnology Research | 113 | View company |
| MeMed | Biotechnology Research | 107 | View company |
| Anima Biotech | Biotechnology Research | 67 | View company |
| BiomX (NYSE: PHGE) | Biotechnology Research | 64 | View company |
| BioLineRx | Biotechnology Research | 54 | View company |
| Bonus Biogroup | Biotechnology Research | 42 | View company |